This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.


Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


Search results

From Proteopedia

You searched for Omalizumab

Jump to: navigation, search

There is no page with the exact title "Omalizumab". The search results for "Omalizumab" are displayed below. You can create a page titled Omalizumab (by clicking on the red link).

For more information about searching Proteopedia, see Help.

To exclude pages titled with 4-character PDB codes, use the checkbox "only Human created pages" at the bottom of this page.

Showing below up to 20 results starting with #1.


View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)

Article title matches

  1. Category:Omalizumab (41 bytes)
    1: List of pages with the keyword Omalizumab

Page text matches

  1. 2xa8 (2,883 bytes)
    2: ==Crystal structure of the Fab domain of omalizumab at 2.41A==
    11: ...l the key IgE residues and their roles in binding omalizumab, CD23, and FcepsilonRI.
  2. 4gt7 (3,601 bytes)
    13: ...s not affect binding of two other IgE-Fc ligands, omalizumab and DARPin E2_79, demonstrating selective blockin...
  3. 4grg (3,512 bytes)
    12: ... identified and an anti-IgE therapeutic antibody (omalizumab) is used to treat severe allergic asthma. However...
  4. User:Anthony Davis/Sandbox1 IgE (6,380 bytes)
    29: ...195) to have five times more affinity to IgE than Omalizumab. Research pertaining to IgE and its FcϵRI recept...
    41: Scheinfeld N. (2005). Omalizumab: A recombinant humanized monoclonal IgE blocking ...
  5. 4x7s (3,457 bytes)
    2: ==Structure of omalizumab Fab fragment crystal form 1==
    11: ...tructural basis for understanding the function of omalizumab, allows optimization of the procedure for complex...
    13: Structure of the omalizumab Fab.,Jensen RK, Plum M, Tjerrild L, Jakob T, Spil...
  6. 4x7t (3,624 bytes)
    2: ==Structure of Omalizumab Fab fragment, crystal form 2==
    12: ...tructural basis for understanding the function of omalizumab, allows optimization of the procedure for complex...
    14: Structure of the omalizumab Fab.,Jensen RK, Plum M, Tjerrild L, Jakob T, Spil...
  7. 5anm (4,690 bytes)
    14: ...e-IgE from human sera to levels ~1 log lower than omalizumab. Our results thus indicate that MEDI4212 is a nov...
  8. 5hys (3,468 bytes)
    2: ==Structure of IgE complexed with omalizumab==
    14: ...s the exchange of cell-bound full-length IgE with omalizumab-resistant IgE-Fc fragments on human basophils. Th...
    16: Structural basis of omalizumab therapy and omalizumab-mediated IgE exchange.,Pennington LF, Tarchevskay...
  9. 5g64 (3,607 bytes)
    12: ...tion and, together with the structure, reveal how omalizumab may accelerate dissociation of receptor-bound IgE...
    14: ...sm of action of the therapeutic anti-IgE antibody omalizumab.,Davies AM, Allan EG, Keeble AH, Delgado J, Cossi...
  10. Category:Omalizumab (41 bytes)
    1: List of pages with the keyword Omalizumab
  11. 6eyn (3,442 bytes)
    11: ...he earlier, clinically approved anti-IgE antibody omalizumab, 8D6 inhibits binding to FcepsilonRI but not CD23...
  12. 6eyo (3,496 bytes)
    11: ...he earlier, clinically approved anti-IgE antibody omalizumab, 8D6 inhibits binding to FcepsilonRI but not CD23...
  13. 6uqr (3,434 bytes)
    14: ...s potent in inhibiting IgE:CD23 interactions than omalizumab. Our data thus provide a structural and mechanist...
    16: ...peutic anti-IgE antibody ligelizumab differs from omalizumab.,Gasser P, Tarchevskaya SS, Guntern P, Brigger D,...
  14. 6tcm (4,011 bytes)
    2: ==Crystal structure of the omalizumab Fab - crystal form I==
    12: ...tures without interfering with the ability of the omalizumab Fab to recognize IgE-Fc; this led to the successf...
    14: Engineering the Fab fragment of the anti-IgE omalizumab to prevent Fab crystallization and permit IgE-Fc ...
  15. 6tcn (4,089 bytes)
    2: ==Crystal structure of the omalizumab Fab - crystal form II==
    12: ...tures without interfering with the ability of the omalizumab Fab to recognize IgE-Fc; this led to the successf...
    14: Engineering the Fab fragment of the anti-IgE omalizumab to prevent Fab crystallization and permit IgE-Fc ...
  16. 6tco (3,972 bytes)
    2: ==Crystal structure of the omalizumab Fab Leu158Pro light chain mutant - crystal form I...
    12: ...tures without interfering with the ability of the omalizumab Fab to recognize IgE-Fc; this led to the successf...
    14: Engineering the Fab fragment of the anti-IgE omalizumab to prevent Fab crystallization and permit IgE-Fc ...
  17. 6tcp (4,030 bytes)
    2: ==Crystal structure of the omalizumab Fab Leu158Pro light chain mutant - crystal form I...
    12: ...tures without interfering with the ability of the omalizumab Fab to recognize IgE-Fc; this led to the successf...
    14: Engineering the Fab fragment of the anti-IgE omalizumab to prevent Fab crystallization and permit IgE-Fc ...
  18. 6tcq (3,909 bytes)
    2: ==Crystal structure of the omalizumab Fab Ser81Arg and Gln83Arg light chain mutant==
    12: ...tures without interfering with the ability of the omalizumab Fab to recognize IgE-Fc; this led to the successf...
    14: Engineering the Fab fragment of the anti-IgE omalizumab to prevent Fab crystallization and permit IgE-Fc ...
  19. 6tcr (3,989 bytes)
    2: ==Crystal structure of the omalizumab Fab Ser81Arg, Gln83Arg and Leu158Pro light chain ...
    12: ...tures without interfering with the ability of the omalizumab Fab to recognize IgE-Fc; this led to the successf...
    14: Engineering the Fab fragment of the anti-IgE omalizumab to prevent Fab crystallization and permit IgE-Fc ...
  20. 6tcs (3,881 bytes)
    2: ==Crystal structure of the omalizumab scFv==
    12: ...tures without interfering with the ability of the omalizumab Fab to recognize IgE-Fc; this led to the successf...
    14: Engineering the Fab fragment of the anti-IgE omalizumab to prevent Fab crystallization and permit IgE-Fc ...

View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)



Search in namespaces:

Include only Seeded (Automatic) pages - only Human created pages
List redirects
Search for

You may also try
Views
Personal tools